Clinical Trials Directory

Trials / Unknown

UnknownNCT05235386

Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.

Detailed description

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department. The quality of oxygen therapy is evaluated by the time spent in the SpO2 target (+/- 2% SpO2 target), time spent in hyperoxemia (\> 5% SpO2 target), time spent in hyperoxemia (\<5% SpO2 target).

Conditions

Interventions

TypeNameDescription
DEVICEAutomated oxygen titrationAutomated oxygen administration to maintain the SpO2 target at a predefined value during emergency length of stay

Timeline

Start date
2022-02-01
Primary completion
2022-03-01
Completion
2022-12-01
First posted
2022-02-11
Last updated
2022-02-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05235386. Inclusion in this directory is not an endorsement.